Neutrophil dysplasia caused by mycophenolate mofetil

Transplantation

Volumn 70, Issue 11 SUPPL., 2000, Pages 1608-1610

  Banerjee, R ^a   Halil, O ^a   Bain, B J ^a   Cummins, D ^a   Banner, N R ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CASE REPORT; CHROMATIN; DYSPLASIA; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORPHOLOGY; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0034671105     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200012150-00012     Document Type: Article

References (10)

1. Purine metabolism and the immunosuppressive effects of mycophenolate mofetil
2. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trials
3. A randomised active controlled trial of mycophenolate mofetil in heart transplant recipients
4. Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: Importance of mycophenolic acid therapeutic drug monitoring
5. Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function
6. Pharmacokinetics of MMF: A short review
7. Hepatic clearance of mycophenolic acid in rats: The importance of binding to plasma protein (Abstract)
8. Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure
9. Relation of mycophenolic acid through levels and adverse events in kidney allograft recipients
10. Mycophenolic acid: Measurement and relationship to pharmacologic effects